Raras
Buscar doenças, sintomas, genes...
Alfa-talassemia
ORPHA:846CID-10 · D56.0CID-11 · 3A50.0OMIM 604131PCDT · SUSDOENÇA RARA

Hemoglobinopatia hereditária caracterizada pela síntese prejudicada das cadeias alfa-globina, levando a um quadro clínico variável, dependendo do número de alelos afetados.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Hemoglobinopatia hereditária caracterizada pela síntese prejudicada das cadeias alfa-globina, levando a um quadro clínico variável, dependendo do número de alelos afetados.

Pesquisas ativas
11 ensaios
28 total registrados no ClinicalTrials.gov
Publicações científicas
3.519 artigos
Último publicado: 2026 Mar

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Europe
Início
All ages
🏥
SUS: Cobertura parcialScore: 45%
PCDT disponível1 medicamentos CEAFCID-10: D56.0
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (1)
0202010317
Eletroforese de hemoglobinaslab_test
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🩸
Sangue
4 sintomas
❤️
Coração
3 sintomas
🫃
Digestivo
3 sintomas
🧠
Neurológico
2 sintomas
😀
Face
2 sintomas
🦴
Ossos e articulações
2 sintomas

+ 15 sintomas em outras categorias

Características mais comuns

90%prev.
Hemoglobina anormal
Muito frequente (99-80%)
90%prev.
Anemia microcítica
Muito frequente (99-80%)
55%prev.
Hematopoiese extramedular
Frequente (79-30%)
55%prev.
Edema generalizado
Frequente (79-30%)
55%prev.
Insuficiência cardíaca congestiva
Frequente (79-30%)
55%prev.
Derrame pericárdico
Frequente (79-30%)
32sintomas
Muito frequente (2)
Frequente (7)
Ocasional (14)
Sem dados (9)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 32 características clínicas mais associadas, ordenadas por frequência.

Hemoglobina anormalAbnormal hemoglobin
Muito frequente (99-80%)90%
Anemia microcíticaMicrocytic anemia
Muito frequente (99-80%)90%
Hematopoiese extramedularExtramedullary hematopoiesis
Frequente (79-30%)55%
Edema generalizadoGeneralized edema
Frequente (79-30%)55%
Insuficiência cardíaca congestivaCongestive heart failure
Frequente (79-30%)55%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico3.519PubMed
Últimos 10 anos200publicações
Pico2025162 papers
Linha do tempo
2026Hoje · 2026🧪 2004Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

2 genes identificados com associação a esta condição. Padrão de herança: Autosomal recessive.

HBA1Hemoglobin subunit alphaDisease-causing germline mutation(s) inModerado
FUNÇÃO

Involved in oxygen transport from the lung to the various peripheral tissues Hemopressin acts as an antagonist peptide of the cannabinoid receptor CNR1 (PubMed:18077343). Hemopressin-binding efficiently blocks cannabinoid receptor CNR1 and subsequent signaling (PubMed:18077343)

LOCALIZAÇÃO

VIAS BIOLÓGICAS (1)
Scavenging of heme from plasma
MECANISMO DE DOENÇA

Heinz body anemias

Form of non-spherocytic hemolytic anemia of Dacie type 1. After splenectomy, which has little benefit, basophilic inclusions called Heinz bodies are demonstrable in the erythrocytes. Before splenectomy, diffuse or punctate basophilia may be evident. Most of these cases are probably instances of hemoglobinopathy. The hemoglobin demonstrates heat lability. Heinz bodies are observed also with the Ivemark syndrome (asplenia with cardiovascular anomalies) and with glutathione peroxidase deficiency.

EXPRESSÃO TECIDUAL(Ubíquo)
Sangue
15499.1 TPM
Baço
90.5 TPM
Pulmão
37.3 TPM
Rim - Medula
20.0 TPM
Rim - Córtex
18.1 TPM
OUTRAS DOENÇAS (9)
alpha thalassemia spectrumhemoglobin H diseaseerythrocytosis, familial, 7Heinz body anemia
HGNC:4823UniProt:P69905
HBA2Hemoglobin subunit alphaDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Involved in oxygen transport from the lung to the various peripheral tissues Hemopressin acts as an antagonist peptide of the cannabinoid receptor CNR1 (PubMed:18077343). Hemopressin-binding efficiently blocks cannabinoid receptor CNR1 and subsequent signaling (PubMed:18077343)

LOCALIZAÇÃO

VIAS BIOLÓGICAS (1)
Scavenging of heme from plasma
MECANISMO DE DOENÇA

Heinz body anemias

Form of non-spherocytic hemolytic anemia of Dacie type 1. After splenectomy, which has little benefit, basophilic inclusions called Heinz bodies are demonstrable in the erythrocytes. Before splenectomy, diffuse or punctate basophilia may be evident. Most of these cases are probably instances of hemoglobinopathy. The hemoglobin demonstrates heat lability. Heinz bodies are observed also with the Ivemark syndrome (asplenia with cardiovascular anomalies) and with glutathione peroxidase deficiency.

EXPRESSÃO TECIDUAL(Ubíquo)
Sangue
80863.6 TPM
Baço
944.8 TPM
Pulmão
456.9 TPM
Rim - Medula
268.9 TPM
Adipose Visceral Omentum
211.0 TPM
OUTRAS DOENÇAS (8)
Heinz body anemiahemoglobin H diseaseerythrocytosis, familial, 7alpha thalassemia spectrum
HGNC:4824UniProt:P69905

Variantes genéticas (ClinVar)

351 variantes patogênicas registradas no ClinVar.

🧬 HBA2: NM_000517.6(HBA2):c.186G>A (p.Lys62=) ()
🧬 HBA2: NM_000517.6(HBA2):c.6dup (p.Leu3fs) ()
🧬 HBA2: NM_000517.6(HBA2):c.163del (p.Gln55fs) ()
🧬 HBA2: NM_000517.6(HBA2):c.153del (p.His51fs) ()
🧬 HBA2: NM_000517.6(HBA2):c.427_429delinsCAT (p.Ter143His) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 2,516 variantes classificadas pelo ClinVar.

1761
755
VUS (70.0%)
Benigna (30.0%)
VARIANTES MAIS SIGNIFICATIVAS
ATRX: NM_000489.6(ATRX):c.2696C>G (p.Thr899Arg) [Uncertain significance]
ATRX: NM_000489.6(ATRX):c.1244C>T (p.Ser415Phe) [Uncertain significance]
ATRX: NM_000489.6(ATRX):c.1225T>G (p.Leu409Val) [Uncertain significance]
ATRX: NM_000489.6(ATRX):c.1328C>A (p.Ala443Glu) [Uncertain significance]
ATRX: NM_000489.6(ATRX):c.2149C>T (p.Pro717Ser) [Uncertain significance]

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
3Fase 34
2Fase 22
1Fase 12
·Pré-clínico10
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 18 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Alfa-talassemia

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

6 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

28 ensaios clínicos encontrados, 11 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

🥈Melhor nível de evidência: Coorte
Timeline de publicações
1.551 papers (10 anos)

Mostrando amostra de 200 publicações de um total de 1.551

#1

Molecular Methods for Rare Hemoglobinopathy Cases: First Brazilian Report of Pediatric Siblings with Hb O-Arab and Alpha-Thalassemia.

Pediatric blood &amp; cancer2026 Mar 15

Hemoglobinopathies are prevalent globally; diagnosis is complex in high genetic admixture populations like Brazil. We report, in two pediatric siblings, the first documented cases in Brazil of heterozygosity for hemoglobin (Hb) O-Arab with coinheritance of α-thalassemia (αα/-α4.2; -α3.7/-α4.2), resulting in microcytic and hypochromic anemia. Electrophoresis, high-performance liquid chromatography, HBB gene sequencing, and multiplex-polymerase chain reaction confirmed these complex genotypes. Although rare, Hb O-Arab significantly impacts clinical status, particularly in patients with coexisting hemoglobinopathies, such as α-thalassemia and Hb S, the latter resulting in a sickle cell disease form. This highlights the crucial role of molecular diagnostics, early screening, and genetic counseling in the accurate management and prevention of misdiagnosis in hemoglobinopathies.

#2

Local heterochromatin enrichment promotes telomere clustering and PML nuclear body assembly at telomeres.

Cell reports2026 Feb 18

The alternative lengthening of telomeres (ALT) pathway is a recombination-based telomere maintenance mechanism used by a subset of human cancers and is characterized by telomere clustering within telomere-associated promyelocytic leukemia (PML) nuclear bodies (APBs). Although ALT telomeres exhibit reduced nucleosome density, they are paradoxically enriched for heterochromatin-associated factors, raising questions about how chromatin state contributes to ALT. Here, we use a targeted system to locally modulate heterochromatin features at telomeres. We show that telomeric heterochromatin promotes telomere clustering and multiple hallmarks of APB-associated telomere processing in ALT-positive (ALT+) cells. Remarkably, molecular tethering of HP1α at telomeres is sufficient to nucleate PML nuclear bodies in non-ALT cells and, in specific contexts, induce biomarkers of ALT-like recombination. We further demonstrate that heterochromatin-driven PML-telomere colocalization is inhibited by α-thalassemia/mental retardation, X-linked and death domain-associated protein (ATRX/DAXX), factors frequently mutated in ALT+ tumors. Together, these findings establish telomeric heterochromatin as a driver of telomere clustering and PML nuclear body assembly, shaping ALT-associated subnuclear compartmentalization.

#3

ATRX loss couples genome instability at a G-rich repeat to dysregulation of human alpha-globin expression.

Nature communications2026 Feb 14

Germline mutations in the chromatin remodelling protein ATRX cause a severe developmental disorder associated with α-thalassemia. In addition, ATRX is amongst the twenty genes most frequently mutated in cancer. How ATRX mutations alter gene expression remains unclear. Using the α-globin locus as a model, here we show that ATRX deficiency downregulates α-globin in a subset of cells exhibiting DNA damage. A G-rich repeat at the α-globin locus serves as a potential site of G-quadruplex formation and DNA damage. ATRX binds this repeat co-transcriptionally, and its loss increases R-loop accumulation at this site, leading to local DNA damage and transcriptional disruption in cis. Deletion of this repeat abolishes this effect, while targeted DNA damage reinstates it. These findings reveal a mechanism linking ATRX's role in genome stability to transcriptional regulation and uncover a molecular basis of human genetic disease mediated via a distal G-rich repeat.

#4

Prevalence of Severe Thalassemia and Performance of Prenatal Screening Tests Among Pregnant Women at Siriraj Thalassemia Center in Thailand.

Clinical and translational science2026 Feb

Severe thalassemia remains a significant public health concern in Southeast Asia. Prenatal screening is an effective strategy for early detection and prevention. This study aimed to determine the prevalence of severe thalassemia and assess the performance of prenatal screening at the Siriraj Thalassemia Center, Siriraj Hospital, Thailand. A retrospective review was conducted using data from January 2018 to December 2023. A total of 18,976 pregnant women underwent initial screening with mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), and hemoglobin (Hb) typing. Of these, 12,499 tested positive. Complete screening data from 6,698 male partners identified 18.3% of couples as high-risk. Deoxyribonucleic acid (DNA) analysis and prenatal diagnostic testing were performed for at-risk pregnancies. Among high-risk couples, 75.2% of fetuses were identified by DNA analysis as being at risk for severe thalassemia, and 34.2% were confirmed as affected. The distribution of severe thalassemia types included Hb Bart's Hydrops Fetalis (15.8%), homozygous β-thalassemia (1.6%), and β-thalassemia/Hb E disease (16.8%). The most frequent α-thalassemia genotype in Hb Bart's cases was homozygous α0-thalassemia (--SEA/--SEA; 96.3%). The most common β-thalassemia mutation was a 4-base pair deletion at codons 41/42 (-TTCT; 40.2%). DNA testing for α-thalassemia showed 100% specificity and positive predictive value (PPV). For β-thalassemia, the sensitivity, specificity, PPV, and negative predictive value (NPV) were 97.6%, 98.9%, 96.1%, and 99.3%, respectively. The findings underscore the effectiveness of prenatal screening and diagnosis in identifying severe thalassemia, highlighting their importance for informing prevention strategies and guiding public health planning in high-prevalence settings.

#5

Homozygous Hb Sallanches (HBA2:c.314G > A): An Uncommon Non-Transfusion Dependent α-Thalassemia with Reticulocytosis.

Indian journal of hematology &amp; blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion2026 Mar

Publicações recentes

Ver todas no PubMed

📚 EuropePMC980 artigos no totalmostrando 200

2026

Exploring the protective effects of thalassemia against malaria in Africa: a systematic review.

Systematic reviews
2026

Implications of Glomus Tumor Pathology and Pain Mechanism for Surgical Treatment.

Annali italiani di chirurgia
2026

Molecular Methods for Rare Hemoglobinopathy Cases: First Brazilian Report of Pediatric Siblings with Hb O-Arab and Alpha-Thalassemia.

Pediatric blood &amp; cancer
2026

Kinetics of antimalarial antibodies in children with common haemoglobinopathies in a Tanzanian population.

Frontiers in immunology
2026

Transforming the treatment of Alpha-Thalassemia: a single-center retrospective study on hematopoietic stem cell transplantation in transfusion-dependent pediatric patients.

Annals of hematology
2026

DNMT3A R882C variant in a patient with a presumed pineal gland tumor, highlighting potential tumor susceptibility in Tatton-Brown-Rahman syndrome.

Cancer genetics
2026

Systematic Review of Non-Coding Genomic Variants in Globin and Non-Globin Clusters and Their Impact on Phenotypic Severity in Thalassemia and Sickle Cell Disease.

Journal of clinical medicine
2026

Difficult Cases in the Diagnosis of Thalassemia Syndromes.

Hemoglobin
2026

Homozygous Hb Sallanches (HBA2:c.314G > A): An Uncommon Non-Transfusion Dependent α-Thalassemia with Reticulocytosis.

Indian journal of hematology &amp; blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion
2026

Altered Brain Structure in an ATRX-Deficient Mouse Model of Autism Spectrum Disorder.

Autism research : official journal of the International Society for Autism Research
2026

Local heterochromatin enrichment promotes telomere clustering and PML nuclear body assembly at telomeres.

Cell reports
2026

α-Thalassemia has no association with asymptomatic Plasmodium falciparum carriage in three ecological zones of Ghana.

Scientific reports
2026

Hemoglobin Bart's disease and the Agrinio mutation: A case report of successful fetal intervention.

Fetal diagnosis and therapy
2026

Diagnostic Limitations of Hemoglobin A1c in the Setting of Compound Hemoglobinopathy: A Case Report of Sickle Cell Disease, Alpha Thalassemia, and Occult Diabetes.

Cureus
2026

ATRX loss couples genome instability at a G-rich repeat to dysregulation of human alpha-globin expression.

Nature communications
2026

Machine learning and AI-Assisted red blood cell morphology analysis for effective thalassemia screening.

Annals of hematology
2025

[Genetic screening and typing study of Thalassemia among ethnic Miao Group in Qianxinan area of China].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2026

Activated partial thromboplastin time prolongation without hemorrhagic dienhesis: a study of a chinese family coexisting with hereditary KNG1 p.Arg240 mutation and --SEA/αα genotype thalassemia.

Annals of hematology
2026

Many faces of non‑deletional α‑thalassaemia variants in neonate and early childhood.

Annals of hematology
2026

Economic burden of non-transfusion-dependent thalassemia in the United States.

Journal of medical economics
2026

Familial erythrocytosis and phenotypic heterogeneity associated with different defects in alpha globin genes: a significant new case of Hb Wroclaw (α88(F9) Ala>Glu; HBA1: c.266C>A).

Clinical chemistry and laboratory medicine
2026

Prevalence of Severe Thalassemia and Performance of Prenatal Screening Tests Among Pregnant Women at Siriraj Thalassemia Center in Thailand.

Clinical and translational science
2026

Risk Factors for Anemia in Silent Carrier or Minor α-Thalassemia.

Hemoglobin
2026

Mild Thalassemic Effect of Heterozygous Hb Sogn in a Large Cohort from Routine Hemoglobinopathy Investigation.

Hemoglobin
2026

Hemoglobin Chapel Hill masquerading as hemoglobin S in newborn sickle cell screening: A case study.

Clinical biochemistry
2026

Analysis of clinical parameters of different types of α-thalassemia children in Hainan region, China.

PeerJ
2026

Molecular and clinical characterization of -α4.2 subtypes in Shenzhen, Southern China.

Hematology (Amsterdam, Netherlands)
2025

Genetic patterns & public health implications of sickle cell anaemia across populations: A systematic review.

The Indian journal of medical research
2025

A New Method for Screening Thalassemia Patients Using Mid-Infrared Spectroscopy.

Diagnostics (Basel, Switzerland)
2025

Innovative Rapid Detection System for Nondeletion-Type α‑Thalassemia via Whole-Blood Amplification and Microfluidic Technology.

ACS omega
2025

[The Role of MiR-709 in Erythroid Development and Its Correlation with Multiple Hematological Diseases].

Zhongguo shi yan xue ye xue za zhi
2025

[Analysis of Gene Types and Clinical Characteristics of Thalassemia in Children in Nanchong Area].

Zhongguo shi yan xue ye xue za zhi
2025

[Screening Results of Thalassemia and Analysis of Rare Genotypes].

Zhongguo shi yan xue ye xue za zhi
2026

ACMG/AMP-Based Variant Classification of a Novel HBA2 Variant (HBA2: C.297del, Hb Taiping) in Compound Heterozygosity With Hb Adana (HBA2:C.179G>A) Causing Non-Deletional Hb H Disease.

International journal of laboratory hematology
2026

Profiling structural variations of the α-globin gene cluster by the single molecule real-time sequencing: remarkable diversity of the spectrum with rare and novel variants identified in a large Chinese cohort.

Human genetics
2025

Structural heterogeneity and functional convergence of transposable elements.

Frontiers in genetics
2025

Prevalence of Haemoglobin Constant Spring in the Malaysian population: Insights from a single-center study.

The Medical journal of Malaysia
2025

Carrier screening for multiple complex monogenic diseases using long-read sequencing: a population-based study of premarital couples in Shanghai.

Human genomics
2025

Analysis of Hematological Parameters in Relation to Genotypes in 497 Patients with Hemoglobin H Disease.

International journal of general medicine
2025

Importance of the 3'UTR region in globin synthesis: identification of two novel HBA1 mutations causing α-Thalassemia.

Annals of hematology
2025

Performance of the automated DNA extraction with MagNA Pure 24 for further genetic testing for hemoglobinopathies with Globin StripAssays.

Wiener klinische Wochenschrift
2025

Family trios/quartets analysis based on the Newborn Genomic Atlas for Thalassemia project in Guangxi.

BMC medicine
2025

Comparative analysis of the frequencies of α-thalassemia-associated mutations in microcytic patients and healthy volunteers in Rio de Janeiro, Brazil.

Anais da Academia Brasileira de Ciencias
2025

Identification of maternal Gγ(Aγδβ)0 thalassemia through retrospective reanalysis of prenatal cfDNA sequencing data.

Annals of medicine
2026

The Application of Machine-Learning Algorithms for Multiclass Classification of Microcytic Anemia Revealed That a Minimum Required Number of Hematological Parameters Is Enough to Achieve High Diagnostic Accuracy.

International journal of laboratory hematology
2025

Interferon dependent immune memory during HSV-1 neuronal latency via increased H3K9me3 and restriction by ATRX.

Nature communications
2025

Co-Occurrence of Urogenital Anomalies and Congenital Heart Disease in a Child With Alpha-Thalassemia Mental Retardation Syndrome Associated With Chromosome 16 Abnormalities due to Partial Monosomy 16p13.3 and Partial Trisomy 16q22.1-q24.3.

Congenital anomalies
2025

Revisiting hemoglobin constant spring: molecular insights, pathophysiological mechanisms, and clinical perspectives.

Orphanet journal of rare diseases
2025

Predicting the Double Heterozygotes of HbE and α-Thalassemia-1 (Southeast Asian Type) Using RapidMiner-Generated Hematologic Algorithm.

Hemoglobin
2025

Hemoglobin suresnes combined with α0-thalassemia: Diagnostic challenges and insights from trio-based whole exome sequencing.

Annals of hematology
2025

Cord Blood-Based Neonatal Screening for Hemoglobinopathies in Northern Tunisia.

International journal of neonatal screening
2026

Genotypic and hematological profiling of thalassemia in reproductive-age and pediatric populations.

Biomedical reports
2025

Cost-Effectiveness Analysis of Different Prenatal Screening Strategies for the Prevention of Severe Thalassemia in Thailand.

ClinicoEconomics and outcomes research : CEOR
2025

Case Report: identification of a novel 9.159-kb deletion in a Chinese α-thalassemia family using single molecule real-time technology sequencing.

Frontiers in genetics
2025

Unlocking Rare Diagnoses: The Essential Role of Molecular Techniques in Hemoglobin Agrinio. A Case Report.

European journal of haematology
2026

Chromatin-associated DEK proteins maintain H3K27me3 balance and coordinate developmental transitions in plants.

The New phytologist
2025

Genetic Analysis and Clinical Relevance of HBA1:c.305T > C (Leu > Pro): A Novel Variant Linked to α-Thalassemia.

Hemoglobin
2025

[Analysis of Thalassemia Gene Variants in the Wuhan Region].

Zhongguo shi yan xue ye xue za zhi
2025

Genotypic and phenotypic characterization of rare globin variants in Northern Guangxi, China.

Frontiers in immunology
2026

Screening, genetic analysis, and clinical transfusion implications of thalassaemia and glucose-6-phosphate dehydrogenase deficiency in blood donors.

Transfusion medicine (Oxford, England)
2025

ATRX: From Chromatin Remodeling to Disease.

Genesis (New York, N.Y. : 2000)
2025

Utility of long-read sequencing to delineate a rare large deletion of beta-globin gene which escaped Sanger sequencing at prenatal diagnosis in a family clustered with hereditary persistence of fetal hemoglobin.

Taiwanese journal of obstetrics &amp; gynecology
2025

Genetic analysis of a fetus with mosaic trisomy 15 with false-negative result in prenatal amniotic fluid karyotype analysis.

Taiwanese journal of obstetrics &amp; gynecology
2026

Tackling the challenge of in utero blood exchange transfusion for fetal anemia at 15 weeks' gestation.

American journal of obstetrics and gynecology
2025

Catalog of 73 novel variants in thalassemia: discoveries and insights.

Human molecular genetics
2025

The values of the cardio-biparietal ratio and cardio-femur ratio in predicting homozygous α-thalassemia-1 fetuses in early and mid-pregnancy.

The journal of maternal-fetal &amp; neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
2026

Novel serum autoantibodies against alpha thalassemia/mental retardation syndrome X-linked, a component of promyelocytic leukaemia nuclear bodies, in dermatomyositis.

Rheumatology (Oxford, England)
2025

A Diverse Genetic Landscape: Thalassemia Genotype Patterns in Myanmar and Cambodian Workers in Southern Thailand.

Hemoglobin
2025

A novel 17.9 kb deletion of the beta-globin gene causing beta-thalassemia trait in a Danish male.

Clinical biochemistry
2025

Influence of Alpha Thalassaemia on Hematological and Clinical Presentations in Patients of Sickle Cell-β-Thalassaemia with IVS I-5 (G→C) Mutation (HBB: C.20A > T/HBB: C.92 + 5G > C).

Hemoglobin
2025

Genotypic Characterization of Thalassemia in Huadu District, Guangzhou, China: A Single-Center Retrospective Study.

Hemoglobin
2025

Elevated haemoglobin A1c confounds thalassaemia diagnosis by lowering HbA2 levels.

Annals of clinical biochemistry
2025

Diagnostic Utility of a Multiplex PCR Assay in Detecting Common Mutations of the α-Globin Gene in α-Thalassemia.

Anemia
2025

Evaluating Dried Blood Spot and Dried Blood Matrix as Alternatives to Venipuncture for Diagnosing Haemoglobinopathies in Adults: A Mass Spectrometric Approach.

Journal of mass spectrometry : JMS
2025

Identification of a novel 10.7 kb deletion (Nanning deletion; -ζ10.7 kb) in a Chinese female.

Molecular biology reports
2025

Machine learning improves detection of alpha thalassemia carriers compared to clinical features.

Scientific reports
2025

Utility of Molecular Sequencing and Hematologic Parameters for Diagnosis of α-Thalassemia: A Perspective of the National Reference Laboratory.

Hemoglobin
2025

Prediction Models of IDH and ATRX Gene Status in Diffuse Gliomas Based on VASARI Features.

AJNR. American journal of neuroradiology
2025

Transient Postpartum Paraparesis Mimicking Guillain-Barré Syndrome Following Labor Epidural Analgesia: A Case Report.

Cureus
2025

Alpha-Thalassemia Unmasked in a Patient With Sickle Cell Trait: A Case Report.

Cureus
2025

Genetic Profiling and frequencies of Modifiers in Transfusion-Dependent Thalassemia.

Pakistan journal of medical sciences
2025

Hemoglobinopathies and iron deficiency among Northeast-Thai blood donors deferred for low hemoglobin.

Scientific reports
2025

Histopathologic and Molecular Evidence of Splenic Infarction Associated with Sickle Cell Trait: An Instructive Case in Central America.

The American journal of tropical medicine and hygiene
2025

Prevalence of double heterozygotes of HbE and α-thal 1 (SEA) type in pregnancies and their partners that received antenatal care at Chiangrai Prachanukroh Hospital and reevaluated the cut-offs for differentiation.

PloS one
2025

Epidemiological study of thalassemia in the Buyi population of Qiannan Prefecture, Guizhou Province, China based on third-generation sequencing.

Annals of hematology
2025

Molecular Characterization of Three Novel Large Deletions Causing α0-Thalassemia.

International journal of molecular sciences
2025

ATRX cooperates with TOP2B for replication fork stability and DNA damage response through G-quadruplex regulation.

Nucleic acids research
2025

Genetic analysis of thalassemia in putian: comparative insights into mutation spectra with other global regions.

Annals of hematology
2025

The diagnosis and clinical characterization of -α3.7/--SEA thalassemia patients: two cases report.

Annals of hematology
2025

Lentiviral vectors for hematopoietic stem cell gene therapy restore α-globin expression in α-thalassemia red blood cells.

Cell reports. Medicine
2025

From CBC to clarity: Interpretable detection of beta-thalassemia carriers in imbalanced datasets.

PloS one
2025

Clinical and Laboratory Parameters in Iraqi Alpha-Thalassemia Pediatric Patients With Different Genetic Profiles, Basrah, Iraq: A Single-Center Study.

Anemia
2025

[Ethnic differences in genotype distribution of thalassemia between Han and Li populations in southern Hainan].

Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]
2025

Clinical application study of a novel fully automatic erythrocyte osmotic fragility analysis system.

Biochemistry and biophysics reports
2025

The ENERGIZE trial: Is mitapivat ready to take center stage in NTDT management?

Med (New York, N.Y.)
2025

[Genetic Differences of Thalassemia Gene Among Ethnic Groups in Hechi, Guangxi].

Zhongguo shi yan xue ye xue za zhi
2025

[Silent α-Thalassemia Complicated with the Alcohol-Induced Secondary Ring Sideroblastic Anemia].

Zhongguo shi yan xue ye xue za zhi
2025

Combined heterozygosity for the highly unstable variant hemoglobin Taybe, and α-thalassemia as a rare cause of hemolytic anemia.

Annals of hematology
2025

A Genetically Confirmed Case of ATR-X Syndrome Without Alpha-Thalassemia: First Case Reported From Jordan.

Cureus
2025

Development of a low-cost and high-throughput LC-MS method for newborn screening of thalassemia and abnormal hemoglobin disorders.

World journal of pediatrics : WJP
2025

Multiplex ligation-dependent probe amplification (MLPA) assay: a single centre experience of MLPA assay for alpha thalassaemia diagnosis.

The Malaysian journal of pathology
2025

Distribution of Hemoglobinopathy Disorders in Al-Kharj Province Based on Data from the Premarital Screening and Genetic Counseling Program.

Medicina (Kaunas, Lithuania)
2025

Decoding Pancreatic Neuroendocrine Tumors: Molecular Profiles, Biomarkers, and Pathways to Personalized Therapy.

International journal of molecular sciences
2026

Clinical implications of expanded carrier screening for pregnancy-related care and individual health.

Fertility and sterility
2025

Prevention and control of thalassemia in Guangdong Province, Southern China: insights from an 11-year retrospective study.

Annals of medicine
2025

Compound Heterozygous Hb Milledgeville With -α4.2 Thalassemia-A Rare and First Reported Cause of Primary Erythrocytosis in an Indian Family.

International journal of laboratory hematology
2025

Newborn Screening for Hemoglobin Disorders.

Clinics in perinatology
2025

Identification of a New δ chain hemoglobin Variant, Hb A2-Malay [δ46(CD5)Gly > Arg, HBD: C.139G > C;316-443A > G].

Hemoglobin
2025

Late Graft Failure Identified by Persistently High Hemoglobin H Levels Post Transplant in a Patient With Alpha Thalassemia Major.

Pediatric blood &amp; cancer
2025

Capillary electrophoresis mis-anchoring in a case of Hb Hope with HbE.

Clinical biochemistry
2025

Evaluation of stability and potential interference on the α-thalassaemia early eluting peak and immunochromatographic strip test for α-thalassaemia --SEA carrier screening.

Clinical chemistry and laboratory medicine
2025

Genetic modifiers of frequent vaso-occlusive hospitalizations among individuals with sickle cell disease (SCD).

Annals of hematology
2025

Study on the diagnostic and differential value of thalassemia through combined blood routine examination and reticulocyte detection.

Frontiers in pediatrics
2025

HbH Disease in an Elderly Man Due to Compound Heterozygosity for Deletional α-Thalassemia and Hb Dubai (HBA2:c.368A > T).

Hemoglobin
2025

Sitosterolemia carrying both ABCG5 and HBA gene mutations: a case report and review of the literature.

Journal of medical case reports
2025

Hematological analysis of alpha-thalassemia: A single-center, retrospective clinical study.

PloS one
2025

A Case of Severe Anemia in Pregnancy Treated With Traditional Chinese Medicine.

Clinical case reports
2025

HbA1c levels in hemoglobin H disease.

Biochemistry and biophysics reports
2025

Continuous-time random walk and fractional order calculus models histogram analysis of glioma biomarkers, including IDH1, ATRX, MGMT, and TERT, on differentiation.

Quantitative imaging in medicine and surgery
2025

Alternative Lengthening of Telomeres: The Need for ATRX Mutations Is Lineage-Dependent.

International journal of molecular sciences
2025

When Unstable Hemoglobin Lansing Interacts with Alpha Thalassemia Along with HbS: An Interesting Case with Unique Clinical Presentation.

Hemoglobin
2025

Clinical and Genetic Predictors of Sickle Cell Nephropathy: A Global Systematic Review.

Omics : a journal of integrative biology
2025

Long-term outcomes of kidney transplantation in a transfusion-dependent alpha-thalassemia patient.

CEN case reports
2025

Development and validation of mPCR-CEFA for detecting multiple deletion and non-deletion thalassemia genotypes.

Frontiers in genetics
2025

Multiclass classification of thalassemia types using complete blood count and HPLC data with machine learning.

Scientific reports
2025

Factors influencing prenatal diagnosis of deletional hemoglobin H disease in thalassemia prevention and control program, Southern China.

Annals of hematology
2025

Alpha-Thalassemia Caused by ααIVSI-1(AGGT> AGAT) (HBA1: c.95 + 1G > A) Mutation and its Combinations with Other Forms of Thalassemia or Hemoglobinopathy in Northern Thailand.

Indian journal of hematology &amp; blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion
2025

Hb Koya Dora: An Under-recognized Variant of Alpha Thalassemia in India.

Indian journal of hematology &amp; blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion
2025

Structural and clinical characterization of Hb Móstoles (HBA2:c.176A>G; p.His59Arg): a new unstable alpha-globin variant with thalassemic features.

American journal of blood research
2025

Detection of Common α-Hemoglobin Variants in Thailand by Using Real-Time PCR with High Resolution Melting Analysis.

Hemoglobin
2025

Phase separated condensates of ATRX regulate neural progenitor identity.

Nature communications
2025

Morphologic and Electrophoretic Features of Hemoglobin Bart's Hydrops Fetalis.

EJHaem
2025

Analysis of clinicopathological and immunohistochemical features of pheochromocytoma/paraganglioma.

Annals of diagnostic pathology
2025

Identification of a novel complex variant in a patient involving the α-globin gene cluster by third-generation sequencing.

Annals of hematology
2025

A novel targeted long-read sequencing-based preimplantation genetic testing method for α-thalassemia (tlrPGT-α-thal).

Journal of assisted reproduction and genetics
2025

Research Parameters in RBC Indices Shows Vital Importance in Screening α-Thalassemia.

International journal of laboratory hematology
2025

HBA2: C.4delG: A Novel Frameshift Mutation Causing α+-Thalassemia Found in a Chinese Family.

Hemoglobin
2025

Consideration of immunochromatographic strip positive results for screening of alpha-thalassemia in elevated hemoglobin F samples.

Scandinavian journal of clinical and laboratory investigation
2025

Role of Amide Proton Transfer Weighted MRI in Predicting MGMTp Methylation Status, p53-Status, Ki-67 Index, IDH-Status, and ATRX Expression in WHO Grade 4 High Grade Glioma.

Tomography (Ann Arbor, Mich.)
2025

Iron overload and morbidities in Chinese with non-transfusion-dependent thalassaemia.

British journal of haematology
2025

International Consensus Guideline on the Diagnosis and Management of Endocrine Complications of β and α Thalassemia in Children and Adolescents.

Hormone research in paediatrics
2025

Mitapivat in adults with non-transfusion-dependent α-thalassaemia or β-thalassaemia (ENERGIZE): a phase 3, international, randomised, double-blind, placebo-controlled trial.

Lancet (London, England)
2025

Enhancing thalassemia carrier detection: Advancing genetic screening strategies in prenatal care.

Journal of the Formosan Medical Association = Taiwan yi zhi
2025

Molecular epidemiology and hematological thresholds for αβ-thalassemia: a retrospective cohort study in the Huizhou region of southern China.

Hematology (Amsterdam, Netherlands)
2025

Advanced molecular approaches to thalassemia disorder and the selection of molecular-level diagnostic testing in resource-limited settings.

Hematology, transfusion and cell therapy
2025

The 1357 bp deletion in β-thalassemia: molecular profiling and hematological characterization in a Guangxi cohort.

Molecular biology reports
2025

A Novel Large Deletion Including the Major Regulatory Element Compounded with SEA Deletion Causing Hydrops-Fetalis-Syndrome.

Hemoglobin
2025

Genotype Distribution and Clinical Characteristics of Thalassemia Patients Needing Transfusion in Yangjiang, Western Guangdong.

Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie
2025

Revealing silent alpha-thalassemia: characterization of novel HBA1 deletion and missense mutation in Tunisian families.

Annals of hematology
2025

Clinical variability in individuals with ATR-X syndrome in the Netherlands.

European journal of medical genetics
2025

MDPNet: a dual-path parallel fusion network for multi-modal MRI glioma genotyping.

Frontiers in oncology
2025

Cognitive decline in an adult with ATR-16 syndrome due to an unbalanced translocation between 11p15.5 and 16p13.3: a case report.

Frontiers in genetics
2025

Misdiagnosis of α-Thalassemia Heterozygotes as Homozygotes Due to Base Mutations in the Primer Binding Region.

Hemoglobin
2025

Prevalence of common autosomal recessive and X-linked conditions in pregnant women in Vietnam: a cross-sectional study.

Scientific reports
2024

Case Report: Acute hepatitis A virus infection presenting with direct antiglobulin test-negative autoimmune hemolytic anemia and α-thalassemia trait.

F1000Research
2025

ATRX ADD domain is a versatile module for recognizing macroH2A, H3, and beyond.

Acta biochimica et biophysica Sinica
2025

Alpha thalassemia/mental retardation X-linked (ATRX) protein expression in human pituitary neuroendocrine tumours and its reported correlation to prognosis and clinical outcomes: A systematic review.

PloS one
2025

Hemoglobin Disorders Associated with Neurological Impairment: First Report of ATR-X Syndrome and Recessive Congenital Methemoglobinemia Type II in Tunisia.

International journal of molecular sciences
2025

Accuracy of Red Blood Cell Parameters in Predicting α0-Thalassemia Trait Among Non-Anemic Males.

Journal of clinical medicine
2025

[Delayed physical growth and related factors in pediatric patients with transfusion-dependent thalassemia].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
2025

Survival and thalassaemia-related complications in HbE/beta-thalassaemia and alpha-thalassaemia: A 10-year longitudinal study in Thailand.

British journal of haematology
2025

Snrnp25 is a candidate for the peri-implantation lethal phenotype of the Hba deletions.

Mammalian genome : official journal of the International Mammalian Genome Society
2025

Long-term efficacy and safety of mitapivat in non-transfusion-dependent α- or β-thalassaemia: An open-label phase 2 study.

British journal of haematology
2025

Alpha+ Thalassemia in Northwestern Tanzania: Molecular and Hematological Insights From Newborn Screening.

Journal of blood medicine
2025

Measures of cellular oxidative damage following vitamin E supplementation in young patients with transfusion-dependent thalassemia: a double-blind randomized controlled trial.

BMC pediatrics
2025

Pipeline embolization in patients with hemoglobinopathies: A cohort study.

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences
2025

The diagnostic and prediction performance of MR diffusion kurtosis imaging in the glioma molecular classification: a systematic review and meta-analysis.

Frontiers in neurology
2025

[Clinical feature and genetic analysis of a case of X-linked alpha-thalassemia mental retardation syndrome neonate caused by ATRX gene variant and literature review].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2025

[Analysis of hematological characteristics of patients with three common deletional β-thalassemias and concomitant α-thalassemia in Huizhou, Guangdong province].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2025

Oncocytic subtype of well differentiated neuroendocrine tumor: clinicopathologic and molecular associations of a cohort diagnosed on fine needle aspiration (FNA).

Journal of the American Society of Cytopathology
2025

Molecular Characterization and Clinical Outcomes of Pancreatic Neuroendocrine Neoplasms Harboring PAK4-NAMPT Alterations.

JCO oncology advances
2025

Prenatal diagnosis and management of fetal anemia caused by hemoglobin H-Adana: A case report.

The journal of obstetrics and gynaecology research
2025

[Analysis of the Results of Thalassemia Gene Screening in 9 334 Cases in Guiyang Region].

Zhongguo shi yan xue ye xue za zhi
2025

Characterization of HbH Disease Caused by Compound Heterozygotes α+-Thalassemia 3.7 kb Deletion and a Large Novel α0-Thalassemia Deletion.

Hemoglobin
2025

Novel variants of the ATRX gene identified in MYCN non-amplified Neuroblastoma in Brazilian patients.

Clinics (Sao Paulo, Brazil)
2025

Clinical experience of the expanded carrier screening for recessive genetic diseases in a large cohort study in Southern central China.

Scientific reports
2025

From pathology to therapy: A comprehensive review of ATRX mutation related molecular functions and disorders.

Mutation research. Reviews in mutation research
2025

A comprehensive case study of deep learning on the detection of alpha thalassemia and beta thalassemia using public and private datasets.

Scientific reports
2025

Evaluated NSUN3 in reticulocytes from HbH-CS disease that reflects cellular stress in erythroblasts.

Annals of hematology
2025

A rare -α27.6 deletion compounded with the hemoglobin constant spring mutation identified in a Chinese couple.

Hematology (Amsterdam, Netherlands)
2025

Development of Polygenic Risk Score for Persistent Albuminuria in Children and Adults With Sickle Cell Anemia.

American journal of hematology
2025

Isocitrate dehydrogenase-mutant astrocytoma in persons aged 55 years and older: Survival differences versus the young.

Journal of neuropathology and experimental neurology
2025

Middle cerebral artery velocity time integral as a predictor of fetal anemia using fetal hemoglobin Bart's disease as study model.

Ultrasound in obstetrics &amp; gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
2025

Detection of a novel large fragment deletion in the alpha-globin gene cluster using the CNVplex technology.

Frontiers in genetics
2025

Prevalence and Detection of Novel Thalassemia Variant hemoglobin J in Extensive Tharu Population.

Annals of African medicine
2024

Detection of Hemoglobin Constant Spring by Capillary Electrophoresis and High-performance Liquid Chromatography: A Study in Kelantan, Malay.

Oman medical journal
2025

Alpha Thalassemia Major: From a Lethal to a Treatable Condition.

Hemoglobin
2025

Evaluation of haemoglobin constant spring phenotypes and their haematological characteristics among high school students in Terengganu, Malaysia: A single - centred study.

Saudi medical journal
2025

Large-Scale Analysis of the Thalassemia Mutation Spectrum in Guizhou Province, Southern China, Using Third-Generation Sequencing.

Clinical genetics
2025

Prevalence of Hemoglobinopathies Among the Kurdish Population in Zakho City, Kurdistan Region, Iraq.

Cureus
2025

Carrier Frequency of Autosomal Recessive Diseases in a Population Attending a Human Fertility Institute in Colombia.

JBRA assisted reproduction
2025

Targeted long-read sequencing facilitates effective carrier screening for complex monogenic diseases including spinal muscular atrophy, α-/β-thalassemia, 21-hydroxylase deficiency, and fragile-X syndrome.

Journal of translational medicine
2025

Prevalence and molecular spectrum of thalassemia in infertile population among different ethnic groups in Hainan Province, China.

Molecular genetics and genomics : MGG
2025

Alpha-globin gene cluster haplotypes and D1S80, D17S5, and TPO VNTR polymorphisms among four ethnic populations from lower northeastern Thailand.

Scientific reports
2025

Diagnosis and Treatment of Alpha Thalassemia Major.

Hemoglobin
2025

Analysis of thalassemia genotypes and HbA2 test results in pregnant women in Shenzhen, China.

Scientific reports
2024

Targeted liquid biopsy for brain tumors.

The journal of liquid biopsy
2025

Establishment of an α-thalassemia mouse model through fetal liver cell transplantation and analysis of hematological parameters.

Scientific reports
2025

The impact of various types of α-thalassemia on perinatal complications and pregnancy outcomes in pregnant women.

Annals of hematology
2025

[Hematological Characteristics of Neonates with Abnormal Hemoglobin and Their Parents in Guangzhou Area].

Zhongguo shi yan xue ye xue za zhi
Ver todos os 980 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Alfa-talassemia.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Alfa-talassemia

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Molecular Methods for Rare Hemoglobinopathy Cases: First Brazilian Report of Pediatric Siblings with Hb O-Arab and Alpha-Thalassemia.
    Pediatric blood &amp; cancer· 2026· PMID 41834360mais citado
  2. Local heterochromatin enrichment promotes telomere clustering and PML nuclear body assembly at telomeres.
    Cell reports· 2026· PMID 41712379mais citado
  3. ATRX loss couples genome instability at a G-rich repeat to dysregulation of human alpha-globin expression.
    Nature communications· 2026· PMID 41688464mais citado
  4. Prevalence of Severe Thalassemia and Performance of Prenatal Screening Tests Among Pregnant Women at Siriraj Thalassemia Center in Thailand.
    Clinical and translational science· 2026· PMID 41612739mais citado
  5. Homozygous Hb Sallanches (HBA2:c.314G&#x2009;&gt;&#x2009;A): An Uncommon Non-Transfusion Dependent &#x3b1;-Thalassemia with Reticulocytosis.
    Indian journal of hematology &amp; blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion· 2026· PMID 41728145mais citado
  6. Role of Immunohistochemistry in the Diagnosis and Clinicopathological Stratification of Gliomas.
    Cureus· 2026· PMID 41994675recente
  7. ATRX loss in sarcomas is associated with dysregulated gene and transposable element expression, loss of DNA methylation, and worse survival.
    ESMO Rare Cancers· 2026· PMID 41994103recente
  8. Pernicious Anemia Resulting in Intramedullary Hemolysis, Masking Underlying Polycythemia Vera and Mild Alpha-Thalassemia-A Case Report.
    Case Rep Hematol· 2026· PMID 41993099recente
  9. A novel polyadenylation signal variant NM_000517.6 (HBA2): c.*92_*97delinsTA causing α-thalassemia in two Chinese families.
    Front Med (Lausanne)· 2026· PMID 41987797recente
  10. HBA2 Gene Conversion Disrupts Reverse Dot-Blot Hybridization Genotyping: A Prenatal Case of Non-Deletional α-Thalassemia Misdiagnosis.
    Hemoglobin· 2026· PMID 41987528recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:846(Orphanet)
  2. OMIM OMIM:604131(OMIM)
  3. MONDO:0011399(MONDO)
  4. Talassemia(PCDT · Ministério da Saúde)
  5. GARD:621(GARD (NIH))
  6. Variantes catalogadas(ClinVar)
  7. Busca completa no PubMed(PubMed)
  8. Artigo Wikipedia(Wikipedia)
  9. Q288714(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Alfa-talassemia
Compêndio · Raras BR

Alfa-talassemia

ORPHA:846 · MONDO:0011399
🇧🇷 Brasil SUS
CEAF
1AMitapivate
Geral
Prevalência
Unknown
Herança
Autosomal recessive
CID-10
D56.0 · Talassemia alfa
CID-11
Ensaios
11 ativos
Início
All ages
Prevalência
0.0 (Europe)
MedGen
UMLS
C0002312
Repurposing
2 candidatos
deferasiroxchelating agent
deferiprone
EuropePMC
Wikidata
Wikipedia
Papers 10a
Evidência
🥈 Coorte
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades